nature.com search

Loading Filters

Showing 1–50 of 73 results

Loading Filters

Research | 2 October 2020
Impact of patient: donor HLA disparity on reduced-intensity-conditioned allogeneic stem cell transplants from HLA mismatched unrelated donors for AML: from the ALWP of the EBMT
- J. Loke
- , M. Labopin
- , C. Craddock
- , D. Niederwieser
- , J. Cornelissen
- , B. Afansayev
- , P. Jindra
- , J. Maertens
- , D. Blaise
- , K. Boriskina
- , M. Gramatzki
- , A. Ganser
- , B. Savani
- , M. Mohty
- & A. Nagler
Bone Marrow Transplantation , 1–8

Rights & permissionsfor article Impact of patient: donor HLA disparity on reduced-intensity-conditioned allogeneic stem cell transplants from HLA mismatched unrelated donors for AML: from the ALWP of the EBMT . Opens in a new window.
Research | 6 November 2019
Autologous hematopoietic stem cell transplantation for relapsed/refractory systemic anaplastic large cell lymphoma. A retrospective analysis of the lymphoma working party (LWP) of the EBMT
- E. Domingo-Domènech
- , A. Boumendil
- , F. Climent
- , H. Sengeloev
- , B. Wahlin
- , W. Wattad
- , M. Arat
- , H. Finel
- , N. Schapp
- , A. Ganser
- , M. Yeshurun
- , V. Pavone
- , J. Snowden
- , J. Finke
- , S. Montoto
- , A. Sureda
- & P. Dreger
Bone Marrow Transplantation 55 , 796–803

Rights & permissionsfor article Autologous hematopoietic stem cell transplantation for relapsed/refractory systemic anaplastic large cell lymphoma. A retrospective analysis of the lymphoma working party (LWP) of the EBMT . Opens in a new window.
Research | 26 May 2017 | Open
Condensed versus standard schedule of high-dose cytarabine consolidation therapy with pegfilgrastim growth factor support in acute myeloid leukemia
- S Jaramillo
- , A Benner
- , J Krauter
- , H Martin
- , T Kindler
- , M Bentz
- , H R Salih
- , G Held
- , C-H Köhne
- , K Götze
- , M Lübbert
- , A Kündgen
- , P Brossart
- , M Wattad
- , H Salwender
- , B Hertenstein
- , D Nachbaur
- , G Wulf
- , H-A Horst
- , H Kirchen
- , W Fiedler
- , A Raghavachar
- , G Russ
- , S Kremers
- , E Koller
- , V Runde
- , G Heil
- , D Weber
- , G Göhring
- , K Döhner
- , A Ganser
- , H Döhner
- & R F Schlenk
Blood Cancer Journal 7 , e564–e564

Rights & permissionsfor article Condensed versus standard schedule of high-dose cytarabine consolidation therapy with pegfilgrastim growth factor support in acute myeloid leukemia . Opens in a new window.
22 August 2017
RNA interference efficiently targets human leukemia driven by a fusion oncogene in vivo
- N Jyotsana
- , A Sharma
- , A Chaturvedi
- , M Scherr
- , F Kuchenbauer
- , L Sajti
- , A Barchanski
- , R Lindner
- , F Noyan
- , K-W Sühs
- , D Grote-Koska
- , K Brand
- , H-P Vornlocher
- , M Stanulla
- , B Bornhauser
- , J-P Bourquin
- , M Eder
- , F Thol
- , A Ganser
- , R K Humphries
- , E Ramsay
- , P Cullis
- & M Heuser
Leukemia 32 , 224–226

Rights & permissionsfor article RNA interference efficiently targets human leukemia driven by a fusion oncogene <i>in vivo</i> . Opens in a new window.
Research | 24 November 2016
Acute myeloid leukemia derived from lympho-myeloid clonal hematopoiesis
- F Thol
- , S Klesse
- , L Köhler
- , R Gabdoulline
- , A Kloos
- , A Liebich
- , M Wichmann
- , A Chaturvedi
- , J Fabisch
- , V I Gaidzik
- , P Paschka
- , L Bullinger
- , G Bug
- , H Serve
- , G Göhring
- , B Schlegelberger
- , M Lübbert
- , H Kirchner
- , M Wattad
- , D Kraemer
- , B Hertenstein
- , G Heil
- , W Fiedler
- , J Krauter
- , R F Schlenk
- , K Döhner
- , H Döhner
- , A Ganser
- & M Heuser
Leukemia 31 , 1286–1295

Rights & permissionsfor article Acute myeloid leukemia derived from lympho-myeloid clonal hematopoiesis . Opens in a new window.
Amendments and Corrections | 7 October 2016
Erratum: Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemia
- V Madan
- , P Shyamsunder
- , L Han
- , A Mayakonda
- , Y Nagata
- , J Sundaresan
- , D Kanojia
- , K Yoshida
- , S Ganesan
- , N Hattori
- , N Fulton
- , K T Tan
- , T Alpermann
- , M C Kuo
- , S Rostami
- , J Matthews
- , M Sanada
- , L-Z Liu
- , Y Shiraishi
- , S Miyano
- , E Chendamarai
- , H A Hou
- , G Malnassy
- , T Ma
- , M Garg
- , L W Ding
- , Q Y Sun
- , W Chien
- , T Ikezoe
- , M Lill
- , A Biondi
- , R A Larson
- , B L Powell
- , M Lübbert
- , W J Chng
- , H F Tien
- , M Heuser
- , A Ganser
- , M Koren-Michowitz
- , S M Kornblau
- , H M Kantarjian
- , D Nowak
- , W K Hofmann
- , H Yang
- , W Stock
- , A Ghavamzadeh
- , K Alimoghaddam
- , T Haferlach
- , S Ogawa
- , L Y Shih
- , V Mathews
- & H P Koeffler
Leukemia 30 , 2430–2430

Rights & permissionsfor article Erratum: Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemia . Opens in a new window.
15 December 2015
Results of a multicenter prospective phase II trial investigating the safety and efficacy of lenalidomide in patients with myelodysplastic syndromes with isolated del(5q) (LE-MON 5)
- E Schuler
- , A Giagounidis
- , D Haase
- , K Shirneshan
- , G Büsche
- , U Platzbecker
- , F Nolte
- , K Götze
- , R F Schlenk
- , A Ganser
- , A Letsch
- , F Braulke
- , M Lübbert
- , G Bug
- , P Schafhausen
- , U Bacher
- , N Gattermann
- , M Wulfert
- , R Haas
- & U Germing
Leukemia 30 , 1580–1582

Rights & permissionsfor article Results of a multicenter prospective phase II trial investigating the safety and efficacy of lenalidomide in patients with myelodysplastic syndromes with isolated del(5q) (LE-MON 5) . Opens in a new window.
16 January 2017
Incidence and prognostic impact of ASXL2 mutations in adult acute myeloid leukemia patients with t(8;21)(q22;q22): a study of the German-Austrian AML Study Group
- N Jahn
- , M Agrawal
- , L Bullinger
- , D Weber
- , A Corbacioglu
- , V I Gaidzik
- , L Schmalbrock
- , F Thol
- , M Heuser
- , J Krauter
- , G Göhring
- , A Kündgen
- , W Fiedler
- , M Wattad
- , G Held
- , C-H Köhne
- , H-A Horst
- , M Lübbert
- , A Ganser
- , R F Schlenk
- , H Döhner
- , K Döhner
- & P Paschka
Leukemia 31 , 1012–1015

Rights & permissionsfor article Incidence and prognostic impact of <i>ASXL2</i> mutations in adult acute myeloid leukemia patients with t(8;21)(q22;q22): a study of the German-Austrian AML Study Group . Opens in a new window.
18 January 2017 | Open
Impact of pretreatment characteristics and salvage strategy on outcome in patients with relapsed acute myeloid leukemia
- R F Schlenk
- , P Frech
- , D Weber
- , P Brossart
- , H-A Horst
- , D Kraemer
- , G Held
- , M Ringhoffer
- , A Burchardt
- , G Kobbe
- , K Götze
- , D Nachbaur
- , T Fischer
- , M Lübbert
- , H R Salih
- , H Salwender
- , G Wulf
- , E Koller
- , M Wattad
- , W Fiedler
- , S Kremers
- , H Kirchen
- , B Hertenstein
- , P Paschka
- , V I Gaidzik
- , V Teleanu
- , M Heuser
- , F Thol
- , K Döhner
- , J Krauter
- , A Ganser
- & H Döhner
Leukemia 31 , 1217–1220

Rights & permissionsfor article Impact of pretreatment characteristics and salvage strategy on outcome in patients with relapsed acute myeloid leukemia . Opens in a new window.
Amendments and Corrections | 2 November 2016
Erratum: RUNX1 mutations in acute myeloid leukemia are associated with distinct clinico-pathologic and genetic features
- V I Gaidzik
- , V Teleanu
- , E Papaemmanuil
- , D Weber
- , P Paschka
- , J Hahn
- , T Wallrabenstein
- , B Kolbinger
- , C H Köhne
- , H A Horst
- , P Brossart
- , G Held
- , A Kündgen
- , M Ringhoffer
- , K Götze
- , M Rummel
- , M Gerstung
- , P Campbell
- , J M Kraus
- , H A Kestler
- , F Thol
- , M Heuser
- , B Schlegelberger
- , A Ganser
- , L Bullinger
- , R F Schlenk
- , K Döhner
- & H Döhner
Leukemia 30 , 2282–2282

Rights & permissionsfor article Erratum: RUNX1 mutations in acute myeloid leukemia are associated with distinct clinico-pathologic and genetic features . Opens in a new window.
2 May 2016
Prevalence, clonal dynamics and clinical impact of TP53 mutations in patients with myelodysplastic syndrome with isolated deletion (5q) treated with lenalidomide: results from a prospective multicenter study of the german MDS study group (GMDS)
- M Mossner
- , J-C Jann
- , D Nowak
- , U Platzbecker
- , A Giagounidis
- , K Götze
- , A Letsch
- , D Haase
- , K Shirneshan
- , F Braulke
- , R F Schlenk
- , T Haferlach
- , P Schafhausen
- , G Bug
- , M Lübbert
- , A Ganser
- , G Büsche
- , E Schuler
- , V Nowak
- , J Pressler
- , J Obländer
- , S Fey
- , N Müller
- , E Lauinger-Lörsch
- , G Metzgeroth
- , C Weiß
- , W-K Hofmann
- , U Germing
- & F Nolte
Leukemia 30 , 1956–1959

Rights & permissionsfor article Prevalence, clonal dynamics and clinical impact of <i>TP53</i> mutations in patients with myelodysplastic syndrome with isolated deletion (5q) treated with lenalidomide: results from a prospective multicenter study of the german MDS study group (GMDS) . Opens in a new window.
4 July 2016
Clinical impact of GATA2 mutations in acute myeloid leukemia patients harboring CEBPA mutations: a study of the AML study group
- F Theis
- , A Corbacioglu
- , V I Gaidzik
- , P Paschka
- , D Weber
- , L Bullinger
- , M Heuser
- , A Ganser
- , F Thol
- , B Schlegelberger
- , G Göhring
- , C-H Köhne
- , U Germing
- , P Brossart
- , H-A Horst
- , D Haase
- , K Götze
- , M Ringhoffer
- , W Fiedler
- , D Nachbaur
- , T Kindler
- , G Held
- , M Lübbert
- , M Wattad
- , H R Salih
- , J Krauter
- , H Döhner
- , R F Schlenk
- & K Döhner
Leukemia 30 , 2248–2250

Rights & permissionsfor article Clinical impact of <i>GATA2</i> mutations in acute myeloid leukemia patients harboring <i>CEBPA</i> mutations: a study of the AML study group . Opens in a new window.
21 May 2014
Low frequency of calreticulin mutations in MDS patients
- M Heuser
- , V Panagiota
- , C Koenecke
- , B Fehse
- , H Alchalby
- , A Badbaran
- , R Shahswar
- , M Stadler
- , M Eder
- , G Göhring
- , A Trummer
- , T Schroeder
- , G Kobbe
- , C Thiede
- , U Platzbecker
- , B Schlegelberger
- , N Kroeger
- , A Ganser
- & F Thol
Leukemia 28 , 1933–1934

Rights & permissionsfor article Low frequency of calreticulin mutations in MDS patients . Opens in a new window.
7 February 2014
Prognostic effect of calreticulin mutations in patients with myelofibrosis after allogeneic hematopoietic stem cell transplantation
- V Panagiota
- , F Thol
- , B Markus
- , B Fehse
- , H Alchalby
- , A Badbaran
- , U Lehmann
- , C Koenecke
- , R Shahswar
- , A Chaturvedi
- , M Stadler
- , M Eder
- , G Göhring
- , M Koenigsmann
- , A Kloos
- , A Trummer
- , T Schroeder
- , G Kobbe
- , C Thiede
- , U Platzbecker
- , B Schlegelberger
- , H-H Kreipe
- , A Ganser
- , N Kröger
- & M Heuser
Leukemia 28 , 1552–1555

Rights & permissionsfor article Prognostic effect of calreticulin mutations in patients with myelofibrosis after allogeneic hematopoietic stem cell transplantation . Opens in a new window.
23 September 2013
Hepatitis E virus infection in a hematopoietic stem cell donor
- C Koenecke
- , S Pischke
- , G Beutel
- , U Ritter
- , A Ganser
- , H Wedemeyer
- & M Eder
Bone Marrow Transplantation 49 , 159–160

Rights & permissionsfor article Hepatitis E virus infection in a hematopoietic stem cell donor . Opens in a new window.
24 February 2015
Frequency and prognostic impact of casein kinase 1A1 mutations in MDS patients with deletion of chromosome 5q
- M Heuser
- , M Meggendorfer
- , M M A Cruz
- , J Fabisch
- , S Klesse
- , L Köhler
- , G Göhring
- , C Ganster
- , K Shirneshan
- , A Gutermuth
- , S Cerny-Reiterer
- , J Krönke
- , V Panagiota
- , C Haferlach
- , C Koenecke
- , U Platzbecker
- , C Thiede
- , T Schroeder
- , G Kobbe
- , S Ehrlich
- , K Stamer
- , K Döhner
- , P Valent
- , B Schlegelberger
- , N Kroeger
- , A Ganser
- , D Haase
- , T Haferlach
- & F Thol
Leukemia 29 , 1942–1945

Rights & permissionsfor article Frequency and prognostic impact of casein kinase 1A1 mutations in MDS patients with deletion of chromosome 5q . Opens in a new window.
7 May 2013
SETBP1 mutation analysis in 944 patients with MDS and AML
- F Thol
- , K J Suchanek
- , C Koenecke
- , M Stadler
- , U Platzbecker
- , C Thiede
- , T Schroeder
- , G Kobbe
- , S Kade
- , P Löffeld
- , S Banihosseini
- , G Bug
- , O Ottmann
- , W-K Hofmann
- , J Krauter
- , N Kröger
- , A Ganser
- & M Heuser
Leukemia 27 , 2072–2075

Rights & permissionsfor article <i>SETBP1</i> mutation analysis in 944 patients with MDS and AML . Opens in a new window.
Research | 23 December 2013
Risk-adapted, treosulfan-based therapy with auto- and allo-SCT for relapsed/refractory aggressive NHL: a prospective phase-II trial
- M Koenigsmann
- , J Casper
- , C Kahl
- , N Basara
- , H G Sayer
- , G Behre
- , S Theurich
- , M Christopeit
- , M Mohren
- , A Reichle
- , B Metzner
- , A Ganser
- , M Stadler
- , L Uharek
- , L Balleisen
- , A Hinke
- , R Hinke
- & D Niederwieser
Bone Marrow Transplantation 49 , 410–415

Rights & permissionsfor article Risk-adapted, treosulfan-based therapy with auto- and allo-SCT for relapsed/refractory aggressive NHL: a prospective phase-II trial . Opens in a new window.
3 September 1998
Effective reversal of a transformed phenotype by retrovirus-mediated transfer of a ribozyme directed against mutant N-ras
- M Scherr
- , AB Maurer
- , S Klein
- , A Ganser
- , JW Engels
- & M Grez
Gene Therapy 5 , 1227–1234

Rights & permissionsfor article Effective reversal of a transformed phenotype by retrovirus-mediated transfer of a ribozyme directed against mutant N-ras . Opens in a new window.
18 February 2003
The emergence of a C/EBPα mutation in the clonal evolution of MDS towards secondary AML
- A Kaeferstein
- , U Krug
- , J Tiesmeier
- , M Aivado
- , M Faulhaber
- , M Stadler
- , J Krauter
- , U Germing
- , W K Hofmann
- , H P Koeffler
- , A Ganser
- & W Verbeek
Leukemia 17 , 343–349

Rights & permissionsfor article The emergence of a C/EBPα mutation in the clonal evolution of MDS towards secondary AML . Opens in a new window.
25 January 2000
Comparison of nested competitive RT-PCR and real-time RT-PCR for the detection and quantification of AML1/MTG8 fusion transcripts in t(8;21) positive acute myelogenous leukemia
- MP Wattjes
- , J Krauter
- , S Nagel
- , O Heidenreich
- , A Ganser
- & G Heil
Leukemia 14 , 329–335

Rights & permissionsfor article Comparison of nested competitive RT-PCR and real-time RT-PCR for the detection and quantification of AML1/MTG8 fusion transcripts in t(8;21) positive acute myelogenous leukemia . Opens in a new window.
1 July 1998
Elevated pretreatment serum levels of soluble vascular cell adhesion molecule 1 and lactate dehydrogenase as predictors of survival in cutaneous metastatic malignant melanoma
- A Franzke
- , M Probst-Kepper
- , J Buer
- , S Duensing
- , R Hoffmann
- , F Wittke
- , M Volkenandt
- , A Ganser
- & J Atzpodien
British Journal of Cancer 78 , 40–45

Rights & permissionsfor article Elevated pretreatment serum levels of soluble vascular cell adhesion molecule 1 and lactate dehydrogenase as predictors of survival in cutaneous metastatic malignant melanoma . Opens in a new window.
15 May 2003
Aberrant methylation and impaired expression of the p15^INK4b cell cycle regulatory gene in chronic myelomonocytic leukemia (CMML)
- M Tessema
- , F Länger
- , J Dingemann
- , A Ganser
- , H Kreipe
- & U Lehmann
Leukemia 17 , 910–918

Rights & permissionsfor article Aberrant methylation and impaired expression of the <i>p15</i><sup>INK4b</sup> cell cycle regulatory gene in chronic myelomonocytic leukemia (CMML) . Opens in a new window.
8 April 2011
ICSBP promoter methylation in myelodysplastic syndromes and acute myeloid leukaemia
- N Otto
- , G Manukjan
- , G Göhring
- , W Hofmann
- , R Scherer
- , J Chacon Luna
- , U Lehmann
- , A Ganser
- , K Welte
- , B Schlegelberger
- & D Steinemann
Leukemia 25 , 1202–1207

Rights & permissionsfor article <i>ICSBP</i> promoter methylation in myelodysplastic syndromes and acute myeloid leukaemia . Opens in a new window.
Research | 21 June 2002
Increased risk of complicated CMV infection with the use of mycophenolate mofetil in allogeneic stem cell transplantation
- L Hambach
- , M Stadler
- , E Dammann
- , A Ganser
- & B Hertenstein
Bone Marrow Transplantation 29 , 903–906

Rights & permissionsfor article Increased risk of complicated CMV infection with the use of mycophenolate mofetil in allogeneic stem cell transplantation . Opens in a new window.
1 October 1998
Risk and outcome in metastatic malignant melanoma patients receiving DTIC, cisplatin, BCNU and tamoxifen followed by immunotherapy with interleukin 2 and interferon alpha2a
- R Hoffmann
- , I Müller
- , K Neuber
- , S Lassmann
- , J Buer
- , M Probst
- , K Oevermann
- , A Franzke
- , H Kirchner
- , A Ganser
- & J Atzpodien
British Journal of Cancer 78 , 1076–1080

Rights & permissionsfor article Risk and outcome in metastatic malignant melanoma patients receiving DTIC, cisplatin, BCNU and tamoxifen followed by immunotherapy with interleukin 2 and interferon alpha2a . Opens in a new window.
Research | 14 June 2010
Prognostic factors in allo-SCT of elderly patients with AML
- J Krauter
- , K Wagner
- , M Stadler
- , E Dammann
- , M Zucknick
- , M Eder
- , S Buchholz
- , E Mischak-Weissinger
- , B Hertenstein
- & A Ganser
Bone Marrow Transplantation 46 , 545–551

Rights & permissionsfor article Prognostic factors in allo-SCT of elderly patients with AML . Opens in a new window.
12 March 1999 | Open
Prognostic impact of in vivo soluble cell adhesion molecules in metastatic renal cell carcinoma
- R Hoffmann
- , A Franzke
- , J Buer
- , S Sel
- , K Oevermann
- , A Duensing
- , M Probst
- , S Duensing
- , H Kirchner
- , A Ganser
- & J Atzpodien
British Journal of Cancer 79 , 1742–1745

Rights & permissionsfor article Prognostic impact of in vivo soluble cell adhesion molecules in metastatic renal cell carcinoma . Opens in a new window.
29 July 2004
Treatment intensity significantly influencing fibrosis in bone marrow independently of the cytogenetic response: meta-analysis of the long-term results from two prospective controlled trials on chronic myeloid leukemia
- G Buesche
- , M Freund
- , R Hehlmann
- , A Georgii
- , A Ganser
- , H Hecker
- , H Heimpel
- , C Fonatsch
- , B Heinze
- , M Pfirrmann
- , S Holgado
- , A Schmeil
- , A Tobler
- , J Hasford
- , T Buhr
- & H-H Kreipe
Leukemia 18 , 1460–1467

Rights & permissionsfor article Treatment intensity significantly influencing fibrosis in bone marrow independently of the cytogenetic response: meta-analysis of the long-term results from two prospective controlled trials on chronic myeloid leukemia . Opens in a new window.
Research | 27 October 2011 | Open
Treatment of everolimus-resistant metastatic renal cell carcinoma with VEGF-targeted therapies
- V Grünwald
- , C Seidel
- , M Fenner
- , A Ganser
- , J Busch
- & S Weikert
British Journal of Cancer 105 , 1635–1639

Rights & permissionsfor article Treatment of everolimus-resistant metastatic renal cell carcinoma with VEGF-targeted therapies . Opens in a new window.
Research | 14 May 1998
Chemotherapy-induced mobilization of karyotypically normal PBSC for autografting in CML
- T Fischer
- , A Neubauer
- , J Mohm
- , D Huhn
- , C Busemann
- , H Link
- , L Arseniev
- , B Büssing
- , J Novotny
- , A Ganser
- , J Duyster
- , D Bunjes
- , S Kreiter
- , W Aulitzky
- , R Hehlmann
- & C Huber
Bone Marrow Transplantation 21 , 1029–1036

Rights & permissionsfor article Chemotherapy-induced mobilization of karyotypically normal PBSC for autografting in CML . Opens in a new window.
9 September 1999
Monitoring of BCR-ABL expression using real-time RT-PCR in CML after bone marrow or peripheral blood stem cell transplantation
- M Eder
- , K Battmer
- , S Kafert
- , A Stucki
- , A Ganser
- & B Hertenstein
Leukemia 13 , 1383–1389

Rights & permissionsfor article Monitoring of BCR-ABL expression using real-time RT-PCR in CML after bone marrow or peripheral blood stem cell transplantation . Opens in a new window.
8 January 2004
A prospective, randomised, phase II study of horse antithymocyte globulin vs rabbit antithymocyte globulin as immune-modulating therapy in patients with low-risk myelodysplastic syndromes
- M Stadler
- , U Germing
- , K-O Kliche
- , K M Josten
- , R Kuse
- , W-K Hofmann
- , H Schrezenmeier
- , J Novotny
- , O Anders
- , H Eimermacher
- , W Verbeek
- , H-H Kreipe
- , H Heimpel
- , C Aul
- & A Ganser
Leukemia 18 , 460–465

Rights & permissionsfor article A prospective, randomised, phase II study of horse antithymocyte globulin <i>vs</i> rabbit antithymocyte globulin as immune-modulating therapy in patients with low-risk myelodysplastic syndromes . Opens in a new window.
1 May 1997
Elevated serum levels of S100 and survival in metastatic malignant melanoma
- J Buer
- , M Probst
- , A Franzke
- , S Duensing
- , J Haindl
- , M Volkenandt
- , F Wittke
- , R Hoffmann
- , A Ganser
- & J Atzpodien
British Journal of Cancer 75 , 1373–1376

Rights & permissionsfor article Elevated serum levels of S100 and survival in metastatic malignant melanoma . Opens in a new window.
8 June 2004 | Open
Activation of protein kinase A (PKA) by 8-Cl-cAMP as a novel approach for antileukaemic therapy
- E M Weissinger
- , K Oettrich
- , C Evans
- , H-G Genieser
- , F Schwede
- , M Dangers
- , E Dammann
- , H-J Kolb
- , H Mischak
- , A Ganser
- & W Kolch
British Journal of Cancer 91 , 186–192

Rights & permissionsfor article Activation of protein kinase A (PKA) by 8-Cl-cAMP as a novel approach for antileukaemic therapy . Opens in a new window.
26 August 2011
Functional role of BAALC in leukemogenesis
- M Heuser
- , T Berg
- , F Kuchenbauer
- , C K Lai
- , G Park
- , S Fung
- , G Lin
- , M Leung
- , J Krauter
- , A Ganser
- & R K Humphries
Leukemia 26 , 532–536

Rights & permissionsfor article Functional role of BAALC in leukemogenesis . Opens in a new window.
29 August 2012
Analysis of NUP98/NSD1 translocations in adult AML and MDS patients
- F Thol
- , B Kölking
- , I H I Hollink
- , F Damm
- , M M van den Heuvel-Eibrink
- , C Michel Zwaan
- , G Bug
- , O Ottmann
- , K Wagner
- , M Morgan
- , W K Hofmann
- , G Göhring
- , B Schlegelberger
- , J Krauter
- , A Ganser
- & M Heuser
Leukemia 27 , 750–754

Rights & permissionsfor article Analysis of NUP98/NSD1 translocations in adult AML and MDS patients . Opens in a new window.
12 February 1999 | Open
Interleukin 10 (IL-10): an immunosuppressive factor and independent predictor in patients with metastatic renal cell carcinoma
- F Wittke
- , R Hoffmann
- , J Buer
- , I Dallmann
- , K Oevermann
- , S Sel
- , T Wandert
- , A Ganser
- & J Atzpodien
British Journal of Cancer 79 , 1182–1184

Rights & permissionsfor article Interleukin 10 (IL-10): an immunosuppressive factor and independent predictor in patients with metastatic renal cell carcinoma . Opens in a new window.
Research | 6 September 2007
Marrow fibrosis and its relevance during imatinib treatment of chronic myeloid leukemia
- G Buesche
- , A Ganser
- , B Schlegelberger
- , N von Neuhoff
- , D Gadzicki
- , H Hecker
- , O Bock
- , B Frye
- & H Kreipe
Leukemia 21 , 2420–2427

Rights & permissionsfor article Marrow fibrosis and its relevance during imatinib treatment of chronic myeloid leukemia . Opens in a new window.
29 November 2002
Efficient gene transfer into the CNS by lentiviral vectors purified by anion exchange chromatography
- M Scherr
- , K Battmer
- , M Eder
- , S Schüle
- , H Hohenberg
- , A Ganser
- , M Grez
- & U Blömer
Gene Therapy 9 , 1708–1714

Rights & permissionsfor article Efficient gene transfer into the CNS by lentiviral vectors purified by anion exchange chromatography . Opens in a new window.
Research | 13 January 2012
Survival, prognostic factors and rates of leukemic transformation in 381 untreated patients with MDS and del(5q): A multicenter study
- U Germing
- , M Lauseker
- , B Hildebrandt
- , A Symeonidis
- , J Cermak
- , P Fenaux
- , C Kelaidi
- , M Pfeilstöcker
- , T Nösslinger
- , M Sekeres
- , J Maciejewski
- , D Haase
- , J Schanz
- , J Seymour
- , M Kenealy
- , R Weide
- , M Lübbert
- , U Platzbecker
- , P Valent
- , K Götze
- , R Stauder
- , S Blum
- , K-A Kreuzer
- , R Schlenk
- , A Ganser
- , W-K Hofmann
- , C Aul
- , O Krieger
- , A Kündgen
- , R Haas
- , J Hasford
- & A Giagounidis
Leukemia 26 , 1286–1292

Rights & permissionsfor article Survival, prognostic factors and rates of leukemic transformation in 381 untreated patients with MDS and del(5q): A multicenter study . Opens in a new window.
19 February 2004
Expression of the p14^ARF tumor suppressor predicts survival in acute myeloid leukemia
- C Müller-Tidow
- , S K Metzelder
- , H Buerger
- , J Packeisen
- , A Ganser
- , G Heil
- , K Kügler
- , G Adigüzel
- , J Schwäble
- , B Steffen
- , W-D Ludwig
- , A Heinecke
- , T Büchner
- , W E Berdel
- & H Serve
Leukemia 18 , 720–726

Rights & permissionsfor article Expression of the p14<sup>ARF</sup> tumor suppressor predicts survival in acute myeloid leukemia . Opens in a new window.
Research | 9 October 1998
Effect of topical oral G-CSF on oral mucositis: a randomised placebo-controlled trial
- M Karthaus
- , C Rosenthal
- , G Huebner
- , H Paul
- , C Elser
- , B Hertenstein
- , J Krauter
- , T Scharmann
- , RG Geissler
- , G Heil
- & A Ganser
Bone Marrow Transplantation 22 , 781–785

Rights & permissionsfor article Effect of topical oral G-CSF on oral mucositis: a randomised placebo-controlled trial . Opens in a new window.
Research | 7 June 2011
Prevalence and prognostic value of IDH1 and IDH2 mutations in childhood AML: a study of the AML–BFM and DCOG study groups
- F Damm
- , F Thol
- , I Hollink
- , M Zimmermann
- , K Reinhardt
- , M M van den Heuvel-Eibrink
- , C M Zwaan
- , V de Haas
- , U Creutzig
- , J-H Klusmann
- , J Krauter
- , M Heuser
- , A Ganser
- , D Reinhardt
- & C Thiede
Leukemia 25 , 1704–1710

Rights & permissionsfor article Prevalence and prognostic value of <i>IDH1</i> and <i>IDH2</i> mutations in childhood AML: a study of the AML–BFM and DCOG study groups . Opens in a new window.
8 November 2011
SF3B1 mutations in myelodysplastic syndromes: clinical associations and prognostic implications
- F Damm
- , F Thol
- , O Kosmider
- , S Kade
- , P Löffeld
- , F Dreyfus
- , A Stamatoullas-Bastard
- , A Tanguy-Schmidt
- , O Beyne-Rauzy
- , S de Botton
- , A Guerci-Bresler
- , G Göhring
- , B Schlegelberger
- , A Ganser
- , O A Bernard
- , M Fontenay
- & M Heuser
Leukemia 26 , 1137–1140

Rights & permissionsfor article <i>SF3B1</i> mutations in myelodysplastic syndromes: clinical associations and prognostic implications . Opens in a new window.
31 August 2000
Oral 9-cis retinoic acid (Alitretinoin) in the treatment of myelodysplastic syndromes: results from a pilot study
- WK Hofmann
- , WJ Kell
- , P Fenaux
- , S Castaigne
- , A Ganser
- , C Chomienne
- , R Burnett
- , C Kowal
- , D Hoelzer
- & AK Burnett
Leukemia 14 , 1583–1588

Rights & permissionsfor article Oral 9-<i>cis</i> retinoic acid (Alitretinoin) in the treatment of myelodysplastic syndromes: results from a pilot study . Opens in a new window.
Research | 1 October 1997
Immune thyroiditis after transplantation of allogeneic CD34⁺ selected peripheral blood cells
- M Karthaus
- , T Gabrysiak
- , G Brabant
- , A Prahst
- , H Link
- , B Soudah
- , RG Geissler
- , H Diedrich
- , A Ganser
- & B Hertenstein
Bone Marrow Transplantation 20 , 697–699

Rights & permissionsfor article Immune thyroiditis after transplantation of allogeneic CD34<sup>+</sup> selected peripheral blood cells . Opens in a new window.
Research | 1 November 2001
Donor cell-derived acute myeloid leukemia developing 14 months after matched unrelated bone marrow transplantation for chronic myeloid leukemia
- L Hambach
- , M Eder
- , E Dammann
- , K Battmer
- , A Stucki
- , G Heil
- , A Ganser
- & B Hertenstein
Bone Marrow Transplantation 28 , 705–707

Rights & permissionsfor article Donor cell-derived acute myeloid leukemia developing 14 months after matched unrelated bone marrow transplantation for chronic myeloid leukemia . Opens in a new window.
22 September 2003
Recombinant factor VIII expression in hematopoietic cells following lentiviral transduction
- A Tiede
- , M Eder
- , M von Depka
- , K Battmer
- , S Luther
- , H-P Kiem
- , A Ganser
- & M Scherr
Gene Therapy 10 , 1917–1925

Rights & permissionsfor article Recombinant factor VIII expression in hematopoietic cells following lentiviral transduction . Opens in a new window.
Research | 19 January 2006
Long-term survival data from a phase 3 study of Filgrastim as an adjunct to chemotherapy in adults with de novo acute myeloid leukemia
- G Heil
- , D Hoelzer
- , M A Sanz
- , K Lechner
- , L Noens
- , J Szer
- , A Ganser
- , J Matcham
- & J Renwick
Leukemia 20 , 404–409

Rights & permissionsfor article Long-term survival data from a phase 3 study of Filgrastim as an adjunct to chemotherapy in adults with <i>de novo</i> acute myeloid leukemia . Opens in a new window.

Quick links